Page last updated: 2024-12-05

nerolidol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

nerolidol: sesquiterpene; RN given refers to cpd without isomeric designation; nerol is also available [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

nerolidol : A farnesane sesquiterpenoid that is dodeca-1,6,10-triene which carries methyl groups at positions 3, 7 and 11 and a hydroxy group at position 3. It is a natural product that is present in various flowers and plants with a floral odor. Chemically, it exists in two geometric isomers, trans and cis forms. It is widely used in cosmetics (e.g. shampoos and perfumes), in non-cosmetic products (e.g. detergents and cleansers) and also as a food flavoring agent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

(6Z)-nerolidol : A nerolidol in which the double bond at position 6 adopts a cis-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

(6E)-nerolidol : A nerolidol in which the double bond at position 6 adopts a trans-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5320128
CHEMBL ID3185053
CHEBI ID173119
SCHEMBL ID7057492
MeSH IDM0112379
PubMed CID5284507
CHEMBL ID25424
CHEBI ID141283
SCHEMBL ID114136
MeSH IDM0112379

Synonyms (114)

Synonym
CHEBI:173119
(6z)-nerolidol
3790-78-1
nerolidol cis-form
cis-nerolidol
(z)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol
(z)-nerolidol
nerolidol isomer
(6z)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol
nerolidol, cis-(+)-
(+)-nerolidol
peruviol
1,6,10-dodecatrien-3-ol, 3,7,11-trimethyl-, (z)-(s)-(+)-
1,6,10-dodecatrien-3-ol, 3,7,11-trimethyl-, [s-(z)]-
nerolidol
cis-nerolidol, >=96.0% (gc)
fqtlclsucsazdy-kamyiiqdsa-
inchi=1/c15h26o/c1-6-15(5,16)12-8-11-14(4)10-7-9-13(2)3/h6,9,11,16h,1,7-8,10,12h2,2-5h3/b14-11-
nsc 60598
dtxsid1047239 ,
tox21_302456
cas-3790-78-1
NCGC00256775-01
dtxcid9027239
unii-81k23def7b
81k23def7b ,
einecs 223-263-5
cis-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol
nerolidol cis-form [mi]
1,6,10-dodecatrien-3-ol, 3,7,11-trimethyl-, (6z)-
nerolidol, cis-
nerolidol, (6z)-(+/-)-
(6z)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol
3,7,11-trimethyl-1,6,10-dodecatriene-3-ol, (z)-(s)-(+)-
SCHEMBL7057492
CHEMBL3185053
AKOS032949863
nerolidol,cis-(sg)
(6z)-(+/-)-nerolidol
Q27269256
(+/-)-cis-nerolidol 100 microg/ml in methanol
1,6,10-dodecatrien-3-ol, 3,7,11-trimethyl-, (6z)-; 1,6,10-dodecatrien-3-ol, 3,7,11-trimethyl-, (z)- (8ci); (6z)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol; (z)-nerolidol; (+/-)-cis-nerolidol; cis-nerolidol
CS-0253665
HY-N1944A
.+/-.-trans-nerolidol
1,6,10-dodecatrien-3-ol, 3,7,11-trimethyl-, (e)-
.beta.-nerolidol
.alpha.-nerolidol
SDCCGMLS-0066709.P001
(6e)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol
3-hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene
fci 119b
3,7,11-trimethyldodeca-1,6,10-trien-3-ol
SPECTRUM5_000460
BSPBIO_002958
7212-44-4
NCGC00095837-01
NCGC00095837-02
SPECTRUM1502251
NCGC00095837-03
trans-nerolidol
CHEMBL25424
(3s)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol
3,7,11-trimethyl-1,6,10-dodecatrien-3-ol
N0454
(6e)-nerolidol
CHEBI:141283
NCGC00255198-01
tox21_301382
cas-7212-44-4
dtxsid2040783 ,
tox21_111527
cas-40716-66-3
dtxcid0020783
40716-66-3
(e)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol ,
einecs 255-053-4
fg5v0n8p2h ,
nerolidol (e)
unii-fg5v0n8p2h
nerolidol trans-form
CCG-38883
BBL018508
AKOS015902890
nerolidol trans-form [mi]
1,6,10-dodecatrien-3-ol, 3,7,11-trimethyl-, (6e)-
nerolidol, trans-
nerolidol, (6e)-(+/-)-
S5345
AKOS025310880
SCHEMBL114136
(6e)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol
Q-201460
3,7,11-trimethyl-1,6,10-dodecatriene-3-ol
(.+/-.)-nerolidol
W-110939
35944-21-9
SR-05000002467-1
sr-05000002467
trans-nerolidol, primary pharmaceutical reference standard
trans-nerolidol, analytical standard
humbertiol
(6e)-(+/-)-nerolidol
Q415421
AS-16074
STL193540
CS-0018255
HY-N1944
trans-3,7,11-trimethyl-dodeca-1,6,10-trien-3-ol
A917868
AS-75500
HY-N6635
CS-0044197
(e)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol, trans-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol

Research Excerpts

Toxicity

Nerolidol was more toxic than either 1,4-cineole or nerolidol (LD₅₀ = 50.0 mg/adult) The aim of this study was to develop nerolidOL-loaded nanospheres.

ExcerptReferenceRelevance
"98 mg/adult) and was more toxic than either 1,4-cineole or nerolidol (LD₅₀ = 50."( Toxicity of Rhododendron anthopogonoides essential oil and its constituent compounds towards Sitophilus zeamais.
Deng, ZW; Du, SS; Liu, QZ; Liu, ZL; Wang, CF; Yang, K; Zhou, YX, 2011
)
0.37
"The aims of this study were to develop nerolidol-loaded nanospheres, and to evaluate their efficacy in vitro and in vivo against Trypanosoma evansi, as well as to determine their physicochemical properties, morphology, and any possible side effect in vitro against peripheral blood mononuclear cell (PBMC)."( Nerolidol nanospheres increases its trypanocidal efficacy against Trypanosoma evansi: New approach against diminazene aceturate resistance and toxicity.
Baldissera, MD; Cossetin, LF; da Silva, AP; Da Silva, AS; Dalla Lana, DF; Grando, TH; Monteiro, SG; Nascimento, K; Sagrillo, MR; Souza, CF; Stefani, LM, 2016
)
0.43

Compound-Compound Interactions

ExcerptReferenceRelevance
" This study aimed to develop and characterize chitosan hydrogels in combination with nerolidol, in order to optimize the antimicrobial and healing properties."( Chitosan Hydrogel in combination with Nerolidol for healing wounds.
Barreto, HM; da Silva Filho, EC; de Lima, IS; Ferreira, MOG; Leite, LLR; Nunes, LCC; Osajima, JA; Ribeiro, AB, 2016
)
0.43

Bioavailability

ExcerptReferenceRelevance
" The resultant sandwich was heat-sealed to produce circle-shaped TTS (20 cm2) that were subjected to bioavailability study in human volunteers against immediate release nicorandil tablet."( Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers.
Al-Saidan, SM; Chandrasekhar, DV; Krishnaiah, YS; Satyanarayana, V, 2005
)
0.33
" NR (Nerolidol) is a natural bioactive molecule which possesses significant antioxidant and anti-inflammatory potential, but suffers from glitches of low solubility, low bioavailability and fast hepatic metabolism."( Nano-engineered nerolidol loaded lipid carrier delivery system attenuates cyclophosphamide neurotoxicity - Probable role of NLRP3 inflammasome and caspase-1.
Ali, J; Azam, F; Barreto, GE; Haque, SE; Iqubal, A; Iqubal, MK; Najmi, AK; Syed, MA, 2020
)
0.56
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" microti at the dosage of 10 and 100mg/kg BW, while the inhibition was low compared with the high doses used."( Inhibitory effect of terpene nerolidol on the growth of Babesia parasites.
AbouLaila, M; Igarashi, I; Sivakumar, T; Yokoyama, N, 2010
)
0.36
"Tiaprofenic acid is a potent analgesic and nonsteroidal anti-inflammatory drug (NSAID) and like any other nonsteroidal anti-inflammatory drug, oral administration of the conventional dosage forms of tiaprofenic acid invariably causes gastrointestinal side effects."( The effect of terpenes on percutaneous absorption of tiaprofenic acid gel.
Kaptan, E; Nuriyev, M; Okyar, A; Ozturk, N; Pala-Kara, Z; Yildiz, A, 2010
)
0.36
" Dosing was done for 14 days along with a single dose of CP 200 on the 7th day."( Nerolidol attenuates cyclophosphamide-induced cardiac inflammation, apoptosis and fibrosis in Swiss Albino mice.
Ahmad, S; Alam, MM; Ali, J; Ansari, MA; Haque, SE; Iqubal, A; Najmi, AK; Sharma, S; Syed, MA, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
nerolidolA farnesane sesquiterpenoid that is dodeca-1,6,10-triene which carries methyl groups at positions 3, 7 and 11 and a hydroxy group at position 3. It is a natural product that is present in various flowers and plants with a floral odor. Chemically, it exists in two geometric isomers, trans and cis forms. It is widely used in cosmetics (e.g. shampoos and perfumes), in non-cosmetic products (e.g. detergents and cleansers) and also as a food flavoring agent.
nerolidolA farnesane sesquiterpenoid that is dodeca-1,6,10-triene which carries methyl groups at positions 3, 7 and 11 and a hydroxy group at position 3. It is a natural product that is present in various flowers and plants with a floral odor. Chemically, it exists in two geometric isomers, trans and cis forms. It is widely used in cosmetics (e.g. shampoos and perfumes), in non-cosmetic products (e.g. detergents and cleansers) and also as a food flavoring agent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency38.08630.000714.592883.7951AID1259369; AID1259392
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency34.37620.001022.650876.6163AID1224839
retinoid X nuclear receptor alphaHomo sapiens (human)Potency23.16840.000817.505159.3239AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency54.48270.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency21.87240.000229.305416,493.5996AID743069
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency61.13060.001723.839378.1014AID743083
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency32.72630.057821.109761.2679AID1159528
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency54.48270.000627.21521,122.0200AID743202; AID743219
Chain A, Ferritin light chainEquus caballus (horse)Potency12.58935.623417.292931.6228AID485281
LuciferasePhotinus pyralis (common eastern firefly)Potency70.97990.007215.758889.3584AID1224835
15-lipoxygenase, partialHomo sapiens (human)Potency12.58930.012610.691788.5700AID887
USP1 protein, partialHomo sapiens (human)Potency39.81070.031637.5844354.8130AID504865
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency45.44800.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency41.19990.000817.505159.3239AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency22.38720.005428.02631,258.9301AID720659
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency42.49390.057821.109761.2679AID1159526; AID1159528
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency63.09570.010039.53711,122.0200AID588547
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency25.06710.000323.4451159.6830AID743065; AID743067
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency0.04050.005612.367736.1254AID624032
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1612103Toxicity in po dosed mouse2018European journal of medicinal chemistry, Sep-05, Volume: 157Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
AID735308Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated TNF-alpha production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1612102Toxicity in po dosed rat2018European journal of medicinal chemistry, Sep-05, Volume: 157Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
AID735305Cytotoxicity against C57BL/6 mouse BMDCs at 2 to 50 microM by MTT assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID358269Cicatrizant activity in mouse assessed as wound healing by tensile strength method2001Journal of natural products, Oct, Volume: 64, Issue:10
(+)-epi-Alpha-bisabolol [correction of bisbolol] is the wound-healing principle of Peperomia galioides: investigation of the in vivo wound-healing activity of related terpenoids.
AID735307Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated IL12 production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID735306Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated IL-12p40 production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID1612101Dermal toxicity in rabbit2018European journal of medicinal chemistry, Sep-05, Volume: 157Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (223)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (0.90)18.7374
1990's5 (2.24)18.2507
2000's32 (14.35)29.6817
2010's125 (56.05)24.3611
2020's59 (26.46)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.46%)5.53%
Trials0 (0.00%)5.53%
Reviews5 (2.30%)6.00%
Reviews2 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other211 (97.24%)84.16%
Other8 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]